HANNAH D LEVAVI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NEW YORK, NY NPI 1376906776
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NY Kite Pharma, Inc. All categories
General Payments — all program years on this page
$1,124.00
- Category: General Payments
- Program years: PY2021–2024
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $726.45 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $526.45 | 7 |
| Consulting Fee | $200.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Kite Pharma, Inc. | $302.55 | 3 |
| SOBI, INC | $200.00 | 1 |
| ABBVIE INC. | $89.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $82.32 | 1 |
| Blueprint Medicines Corporation | $30.37 | 1 |
| GlaxoSmithKline, LLC. | $21.26 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104165066 | ABBVIE INC. | $89.95 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116326840 | GlaxoSmithKline, LLC. | $21.26 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128609661 | Kite Pharma, Inc. | $41.67 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128609663 | Kite Pharma, Inc. | $127.35 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128609665 | Kite Pharma, Inc. | $133.53 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141440773 | SOBI, INC | $200.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1144961662 | Takeda Pharmaceuticals U.S.A., Inc. | $82.32 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147455595 | Blueprint Medicines Corporation | $30.37 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.